Table 1 The mean, median, and interquartile range of serum CA199 levels U/mL for healthy controls and patients with diabetes or other cancers
From: Elevated serum CA199 levels in patients suffering type 2 diabetes vs. various types of cancer
CA199 | n | Mean (SD) | Median | InterQuartile Range | P value |
|---|---|---|---|---|---|
Healthy controls | 2464 | 15.4(8.7) | 13.0 | 12.1 | 1.00 |
Type 2 diabetes | 688 | 49.2(30.2) | 38.9 | 21.7 | < 0.01 |
Esophagus cancer | 162 | 71.7(84.7) | 42.6 | 38.7 | < 0.01 |
Lung cancer | 468 | 110.6(142.9) | 53.6 | 74.1 | < 0.01 |
Pancreatic cancer | 102 | 182.6(167.1) | 100.5 | 231.6 | < 0.01 |
Ovarian cancer | 118 | 78.8(65.3) | 53.0 | 61.3 | < 0.01 |
Breast cancer | 152 | 71.2(88.3) | 38.0 | 33.6 | < 0.01 |
Rectum cancer | 419 | 112.4(148.4) | 51.9 | 67.7 | < 0.01 |
Prostate cancer | 48 | 51.7(35.6) | 38.2 | 22.4 | < 0.01 |
Bladder cancer | 36 | 106.0(151.1) | 44.3 | 83.1 | < 0.01 |
Liver cancer | 189 | 119.5(139.0) | 64.4 | 96.2 | < 0.01 |
Gastric cancer | 256 | 134.3(139.9) | 71.9 | 134.9 | < 0.01 |
Cervical cancer | 95 | 90.9(107.5) | 46.5 | 53.2 | < 0.01 |
Colon cancer | 282 | 160.6(187.1) | 74.4 | 164.9 | < 0.01 |
Lymphoma | 33 | 67.6(63.2) | 42.6 | 43.7 | < 0.01 |
Thyroid cancer | 36 | 43.5(19.7) | 37.9 | 23.1 | < 0.01 |
Intracranial tumors | 47 | 59.6(110.0) | 37.6 | 39.0 | < 0.01 |
Nasopharyngeal laryngeal cancer | 46 | 50.0(33.3) | 37.1 | 25.0 | < 0.01 |